USA-USFDACVM-2025-US-075145
Received 2025-12-23 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (4.717 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Diarrhoea
- Body systems
- Digestive
- Outcomes
- Ongoing
Roxee Medication Guide
Meloxicam
Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.
Both
Reference complete
FDA data linked
Rx required
Liquid (Suspension)
Multiple FDA labelers
Official label facts
Owner quick guide first
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Data freshness
Reference facts
Reference refreshed
Jun 22, 2026, 10:41 a.m.
These are the reference facts Roxee uses on browse cards and quick facts.
FDA applications
FDA application data refreshed
Jun 22, 2026, 10:41 a.m.
Sponsor, product, and application records imported from Animal Drugs @ FDA.
Safety reports
Safety data refreshed
Jun 21, 2026, 5:14 a.m.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Source timing details
Source timing details
-
Reference facts:
Source Roxee
| Refreshed Jun 22, 2026, 10:41 AM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Jun 22, 2026, 10:40 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed May 1, 2026, 10:01 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Jun 22, 2026, 10:41 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Image coming soon
Meloxicam
Meloxicam
Drug type: Generic ingredient • Branded profile • FDA branded products available
Both
Liquid (Suspension)
Rx required
100% reference complete
Species: Both
Manufacturer: Multiple FDA labelers
Medication Snapshot
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Meloxicam
For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery. For the control of pain and inflammation associated with osteoarthritis in dogs. Species commonly shown: Both, Dog, Cat.
Generic name
Meloxicam
Brand names
Metacam® Oral Suspension, Metacam® 5 mg/mL Solution for Injection, OroCAM® Transmucosal Oral Spray, Meloxicam Injection
Manufacturer
Multiple FDA labelers
Species
Both, Dog, Cat
Dosage forms
Liquid (Suspension), Liquid (Solution), Transmucosal Oral Spray, Sterile Solution
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Metacam® Oral Suspension
Metacam® 5 mg/mL Solution for Injection
OroCAM® Transmucosal Oral Spray
Meloxicam Injection
Loxicom®
Meloxicam Solution for Injection
Meloxidyl®
Meloxicam
Meloxisol™
Meloxicam Oral Suspension
X
Metacam
MELOXIDYL
Ostilox
Loxicom
Meloxivet
Alloxate
Dosage forms
Liquid (Suspension)
Liquid (Solution)
Transmucosal Oral Spray
Sterile Solution
Solution For Injection
Oral Suspension
Injectable Solution
Indications / Uses
For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery. For the control of pain and inflammation associated with osteoarthritis in dogs.
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Side Effects
Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in 'Neurological'), Anorexia, Death by euthanasia, Death.
FAQ
Both, Dog, Cat
Yes. Roxee shows this as prescription-only.
Liquid (Suspension), Liquid (Solution), Transmucosal Oral Spray, Sterile Solution
Related Medications
Related Conditions
Source Transparency
- Verified source: https://www.roxee.ai/meds/
- Verified source: https://animaldrugsatfda.fda.gov
- Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
- Verified source: https://api.fda.gov/animalandveterinary/event.json
- Verified source: https://www.roxee.ai/conditions/
- Verified source: https://www.accessdata.fda.gov/spl/data/19581797-aef3-4008-90f0-3d620380b1a0/19581797-aef3-4008-90f0-3d620380b1a0.xml
- Last refreshed: Jun 22, 2026, 10:41 a.m.
- Last verified: Feb 12, 2026, 10:44 p.m.
- Validation status: Complete
Add to My Pet's Medications
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continuePet Owner Quick Guide
Start here first for the safest next-step summary before the deeper medication detail.
Used for:
Loxicom® oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
- For oral use in dogs only
- Do not use in cats
- Acute renal failure and death have been associated with the use of meloxicam in cats
- Repeated use of meloxicam in cats has been associated with acute renal failure and death
- Do not administer additional injectable or oral meloxicam to cats
- wobbly/unsteady walking (1 reports)
- Dehydration (1 reports)
- Dehiscence (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
Regulatory restrictions are shown in Vet View.
What to tell or ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Research brief
Medication Research Insights
A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.
What to know
Evidence-backed context
Limited
Roxee has limited cited overview evidence for Meloxicam; use the official documents and your veterinarian's instructions for product-specific decisions.
Source: openFDA case USA-USFDACVM-2025-US-054641
Safety signal coverage
Reported signals
32 tracked reaction signals; 32 reported cases; 25 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.
Source: openFDA case USA-USFDACVM-2025-US-054641
Interpretation guardrail
Not causation
Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.
Evidence tension
Stronger signal
Label / review
Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.
Source: openFDA case USA-USFDACVM-2025-US-054641
Weaker signal
Reported data
Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.
Reaction signal map
Most reported reactions
Top terms
Unsteady walking (ataxia) (1 reports), Dehydration (1 reports), Dehiscence (1 reports), Decreased cholesterol (1 reports), Decreased blood urea nitrogen (BUN) or creatinine (1 reports)
Body systems represented
Signal grouping
Digestive (5), Skin & allergy (3), Neurologic (1), Behavior (1)
Species and breed lens
Species represented in reports
Species lens
Cat (20 reports), Dog (12 reports)
Breed metadata in reports
Metadata only
Domestic Shorthair (2), Chihuahua (2), Spaniel - King Charles Cavalier (1), Domestic Mediumhair (1). These are report metadata, not proof that a breed is at higher risk.
What your vet may verify
Fit for this patient
Vet check
Verify whether Meloxicam fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.
Evidence limitations
Evidence review
Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.
What to watch next
Watch list
Owner-safe
For oral use in dogs only, Do not use in cats, Acute renal failure and death have been associated with the use of meloxicam in cats, Repeated use of meloxicam in cats has been associated with acute renal failure and death, Do not administer additional injectable or oral meloxicam to cats
Call sooner if
Escalation
Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.
Bottom line: Use this Meloxicam brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
- openFDA case USA-USFDACVM-2025-US-054641 · adverse_reaction · adverse reactions
- Contraindication source · fda_animal_drugs · warnings contraindications
- FDA application profile · official_label · quick facts
- FDA application profile · official_label · quick facts
- Medication usage source · fda_animal_drugs · quick facts
- FOI · document · documents
- Labeling · document · documents
- SPL · document · documents
Evidence
Review status / Updated / Sources
Review status: Clinical reviewer not listed
Updated: February 12, 2026, 10:44 PM UTC
Sources:
- FDA application profile · official_label
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Meloxicam Oral Suspension · official_label
- openFDA case USA-USFDACVM-2025-US-054641 · adverse_reaction
Safety & side effects
Side effects to monitor:
- For oral use in dogs only
- Do not use in cats
- Acute renal failure and death have been associated with the use of meloxicam in cats
- Repeated use of meloxicam in cats has been associated with acute renal failure and death
- Do not administer additional injectable or oral meloxicam to cats
Most reported reactions:
- Unsteady walking (ataxia) (1 reports)
- Dehydration (1 reports)
- Dehiscence (1 reports)
Emergency warning signs:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Vet Fast Scan
Source-backed clinical checkpoints for quick review.
FDA-labeled species
Cat, Dog
Indication / use
Loxicom® oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
Form / route / dose
Form: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution, Transmucosal Oral Spray
Route: Intravenous, Oral, Subcutaneous
Confirm product label and patient-specific plan.
Route: Intravenous, Oral, Subcutaneous
Confirm product label and patient-specific plan.
Warnings
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not…
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs
- A-200786-E-0003-OT-AA_PI.pdf Official label / PI
- A-200727-G-0031-FL-AA_PI.pdf Official label / PI
- N-141219-C-0098-NL-AA_PI.pdf Official label / PI
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Multiple FDA labelers
Form: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution
Identifiers:
ANADA: 200485
ANADA: 200491
ANADA: 200497
ANADA: 200540
ANADA: 200550
ANADA: 200727
ANADA: 200786
ANADA: 200794
ANADA: 200816
ANADA: 200817
NADA: 141213
NADA: 141219
NADA: 141346
NDC Package: 0010-6013-01
NDC Package: 0010-6014-01
NDC Package: 0010-6014-02
NDC Package: 0010-6015-01
NDC Package: 0010-6015-02
NDC Package: 0010-6015-03
NDC Package: 0010-6015-04
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200786 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200794 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Reported case explorer
Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
22
Matching reports
8
Active filters
1
Selected filters
Body system: Digestive
Clear
Drill into common report signals
Showing up to 50 matching reports.
USA-USFDACVM-2025-US-074369
Received 2025-12-17 · MSK · MSK
- Species
- Dog
- Breed
- Chihuahua
- Size / weight
- Under 10 lb (3.175 Kilogram)
- Age
- 4-7 years (4 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- DiarrhoeaAnorexiaLack of efficacy - NOS
- Body systems
- DigestiveEffectiveness
- Outcomes
- Recovered/Normal
USA-USFDACVM-2025-US-074939
Received 2025-12-16 · MSK · MSK
- Species
- Dog
- Breed
- Chihuahua
- Size / weight
- Under 10 lb (3.674 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- CoughBloody diarrhoeaAspiration pneumoniaVomitingDeath
- Body systems
- OtherDigestive
- Outcomes
- Died
USA-USFDACVM-2025-US-074370
Received 2025-12-16 · MSK · MSK
- Species
- Dog
- Breed
- Terrier - Silky
- Size / weight
- 10-24 lb (6.35 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Intact
- Region
- USA
- Reactions
- AnorexiaHaematocheziaVomiting
- Body systems
- DigestiveOther
- Outcomes
- Outcome Unknown
USA-USFDACVM-2025-US-074255
Received 2025-12-15 · MSK · MSK
- Species
- Dog
- Breed
- Terrier - Jack Russell
- Size / weight
- 10-24 lb (6.214 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Inappropriate elimination NOSProprioception deficitWeight lossVomitingDiarrhoeaProteinuriaElevated globulinsNeutrophiliaAbnormal radiograph finding
- Body systems
- OtherDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-073547
Received 2025-12-15 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Mediumhair
- Size / weight
- Under 10 lb (2.404 Kilogram)
- Age
- 8+ years (18 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Behavioural disorder NOSTrismusDysphoriaDilated pupilsTwitchingAppetite lossConstipationNot sleepingAtaxiaNot drinkingBlood in urineCystitisHyperactivitySniffingDecreased appetite
- Body systems
- BehaviorOtherSkin & allergyDigestiveNeurologic
- Outcomes
- Outcome Unknown
USA-USFDACVM-2025-US-071574
Received 2025-12-05 · MSK · MSK
- Species
- Dog
- Breed
- Spitz - German Pomeranian
- Size / weight
- Under 10 lb (1.633 Kilogram)
- Age
- 4-7 years (4 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Decreased appetiteVomiting bileDiarrhoeaElectrolyte disorderHypoalbuminaemiaDecreased cholesterol (total)Low creatinineWeight loss
- Body systems
- DigestiveOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-073590
Received 2025-12-04 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- Under 10 lb (4.5 Kilogram)
- Age
- 1-3 years (2 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- VomitingNot urinatingNot defecatingMouth ulcerNot eatingNot drinkingRenal failureMedication error NOSBlood in vomitDeath by euthanasia
- Body systems
- DigestiveOther
- Outcomes
- Euthanized
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
32
Serious reports
25
Species represented
2
Grouped by Body System
Digestive (5)
· Loss of appetite, Decreased appetite, Bloody diarrhoea
Skin & allergy (3)
· Hair loss at application site, Biting - pruritus, Application site hair loss
Neurologic (1)
· Unsteady walking (ataxia)
Behavior (1)
· Behavioral disorder (unspecified)
Other (22)
· Dehydration, Dehiscence, Decreased cholesterol
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Neurologic | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Digestive | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 |
Species coverage: Cat (20) Dog (12)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Neurologic | Dog | Serious | - | 1 | |
| Digestive | Dog | Non-serious | - | 1 | |
| Skin & allergy | Cat | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Skin & allergy | Dog | Non-serious | - | 1 | |
| Behavior | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Skin & allergy | Cat | Non-serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-054641
Source Documents
The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.
Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.
A-200786-E-0003-OT-AA_PI.pdf
Official label / PI · Labeling
A-200727-G-0031-FL-AA_PI.pdf
Official label / PI · Labeling
N-141219-C-0098-NL-AA_PI.pdf
Official label / PI · Labeling
Full source previews and metadata remain in the veterinary/professional layer.
Owner handouts
0No owner handouts linked yet.
Official label / PI
16SPL
38FOI
15A-200786-E-0003-OT-AA_PI.pdf
Official label / PI · Labeling
A-200727-G-0031-FL-AA_PI.pdf
Official label / PI · Labeling
N-141219-C-0098-NL-AA_PI.pdf
Official label / PI · Labeling
UCM050394.pdf
Official label / PI · Labeling
UCM422143.pdf
Official label / PI · Labeling
N-141213-G-0122-FL-AA_CIS.pdf
Official label / PI · Labeling
N-141213-G-0122-FL-AA_CIS.pdf
Official label / PI · Labeling
A-200485-C-0047-NL-AA_PI.pdf
Official label / PI · Labeling
A-200491-C-0034-NL-AA_PI.pdf
Official label / PI · Labeling
A-200540-C-0029-NL-AA_PI.pdf
Official label / PI · Labeling
A200497_Client_Info_Sheet.pdf
Official label / PI · Labeling
A200497_Package_Insert.pdf
Official label / PI · Labeling
ANADA 200550 Package Insert and Client Info Sheet for Dogs.pdf
Official label / PI · Labeling
ANADA 200550 Package Insert and Client Info Sheet for Dogs.pdf
Official label / PI · Labeling
UCM342580.pdf
Official label / PI · Labeling
UCM422174.pdf
Official label / PI · Labeling
Loxicom®
SPL · SPL
FDA Structured Product Label
Loxicom®
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Norbrook Laboratories, Ltd.
- ANADA
- 200-786
- Status
- RX
- Form
- Oral Suspension
- Route
- Oral
Composition / specifications
0.5 mg/mL
Dogs
Indication
Loxicom® oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on thefirst day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Meloxisol™
SPL · SPL
FDA Structured Product Label
Meloxisol™
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Cronus Pharma Specialities India Private Ltd.
- ANADA
- 200-794
- Status
- RX
- Form
- Oral Suspension
- Route
- Oral
Composition / specifications
Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Meloxicam Oral Suspension
SPL · SPL
FDA Structured Product Label
Meloxicam Oral Suspension
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Felix Pharmaceuticals Pvt. Ltd.
- ANADA
- 200-817
- Status
- RX
- Form
- Oral Suspension
- Route
- Oral
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Meloxisol™
SPL · SPL
FDA Structured Product Label
Meloxisol™
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Cronus Pharma Specialities India Private Ltd.
- ANADA
- 200-816
- Status
- RX
- Form
- Oral Suspension
- Route
- Oral
Composition / specifications
1.5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Meloxicam
SPL · SPL
FDA Structured Product Label
Meloxicam
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Felix Pharmaceuticals Pvt. Ltd.
- ANADA
- 200-727
- Status
- RX
- Form
- Injectable Solution
- Route
- Intravenous, Subcutaneous
- Species
- Dog • Cat
Composition / specifications
5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Meloxicam injection should be administered initially as a single dose, at0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose of Meloxicam injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated. To ensure accuracy of dosing, the use of a 1 mL graduated syringe is recommended.
Metacam® 5 mg/mL Solution for Injection
SPL · SPL
FDA Structured Product Label
Metacam® 5 mg/mL Solution for Injection
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Boehringer Ingelheim Animal Health USA, Inc.
- NADA
- 141-219
- Status
- RX
- Form
- Liquid (Solution)
- Route
- Subcutaneous, Intravenous
- Species
- Dog • Cat
Composition / specifications
Each milliliter of solution contains 5.0 milligrams (mg) meloxicam.
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery.
Dosage
Administer 0.14 mg/lb (0.3 milligram per kilogram) body weight as a single, one-time subcutaneous injection.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer 0.09 mg per pound (0.2 milligram per kilogram) body weight by intravenous or subcutaneous injection on the first day of treatment. For treatment after day 1, administer meloxicam suspension orally at 0.045 mg/lb (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Metacam® Oral Suspension
SPL · SPL
FDA Structured Product Label
Metacam® Oral Suspension
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Boehringer Ingelheim Animal Health USA, Inc.
- NADA
- 141-213
- Status
- RX
- Form
- Liquid (Suspension)
- Route
- Oral
- Species
- Dog
Composition / specifications
Each milliliter of suspension contains 0.5 or 1.5 milligrams (mg) meloxicam.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For oral use in dogs only.
Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.
Meloxicam Injection
SPL · SPL
FDA Structured Product Label
Meloxicam Injection
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Accord Healthcare, Inc.
- ANADA
- 200-485
- Status
- RX
- Form
- Sterile Solution
- Route
- Subcutaneous, Intravenous
- Species
- Dog • Cat
Composition / specifications
5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated.
Limitations
Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
Loxicom®
SPL · SPL
FDA Structured Product Label
Loxicom®
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Norbrook Laboratories, Ltd.
- ANADA
- 200-491
- Status
- RX
- Form
- Solution For Injection
- Route
- Intravenous, Subcutaneous
- Species
- Dog • Cat
Composition / specifications
5 mg/mL meloxicam solution
Dogs
Indication
Indicated in dogs for the control of pain and inflammation
associated with osteoarthritis.
Dosage
Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously |IV| or subcutaneously (SQ), fallowed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight either mixed with food or placed directly in the mouth.
Limitations
Do not administer a second dose of meloxicam.
Do not follow the single, one-time dose of meloxicam with any other NSAID.
Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.
Cats
Indication
For the control ot postoperative pain and inflammation associated with orthopedic surgery, ovariohystarectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight.
Limitations
Do not administer a second dose of meloxicam.
Do not follow the single, one-time dose of meloxicam with any other NSAID.
Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.
Meloxicam Solution for Injection
SPL · SPL
FDA Structured Product Label
Meloxicam Solution for Injection
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Dechra Veterinary Products LLC
- ANADA
- 200-540
- Status
- RX
- Form
- Sterile Solution
- Route
- Intravenous, Subcutaneous
- Species
- Dog • Cat
Composition / specifications
5 mg/mL
<strong>Dogs</strong>
Indication
For the control of pain and inflammation associated with osteoarthritis
Dosage
Meloxicam Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
<strong>Cats</strong>
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery
Dosage
Administer a single, one-time subcutaneous dose of Meloxicam Solution for Injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
Loxicom®
SPL · SPL
FDA Structured Product Label
Loxicom®
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Norbrook Laboratories, Ltd.
- ANADA
- 200-497
- Status
- RX
- Form
- Oral Suspension
- Route
- Oral
- Species
- Dog
Composition / specifications
1.5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
On the first day of treatment, administer 0.09 mg/lb (0.2 mg/kg). For all treatments after day 1, administer once daily at a dose of 0.045 mg/lb (0.1 mg/ kg).
Limitations
For oral use in dogs only.
Meloxidyl®
SPL · SPL
FDA Structured Product Label
Meloxidyl®
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Ceva Sante Animale
- ANADA
- 200-550
- Status
- RX
- Form
- Oral Suspension
- Route
- Oral
- Species
- Dog
Composition / specifications
Each milliliter of suspension contains 1.5 milligrams (mg) meloxicam.
Label highlights
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs
Dosage
Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
OroCAM® Transmucosal Oral Spray
SPL · SPL
FDA Structured Product Label
OroCAM® Transmucosal Oral Spray
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Zoetis Inc.
- NADA
- 141-346
- Status
- RX
- Form
- Transmucosal Oral Spray
- Route
- Oral
- Species
- Dog
Composition / specifications
Each milliliter of solution contains 5 milligrams (mg) meloxicam.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer 0.1 mg per kilogram of body weight once daily using the metered dose pump.
Limitations
For oral use in dogs only.
Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer meloxicam transmucosal oral spray to cats.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
OstiLox SPL
SPL · Structured Product Label
FDA Structured Product Label XML for OstiLox. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Loxicom SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Loxicom. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Metacam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Metacam. Use the source link for the full official labeling record.
Loxicom SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Loxicom. Use the source link for the full official labeling record.
Ostilox SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Ostilox. Use the source link for the full official labeling record.
MELOXIDYL SPL
SPL · Structured Product Label
FDA Structured Product Label XML for MELOXIDYL. Use the source link for the full official labeling record.
Loxicom SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Loxicom. Use the source link for the full official labeling record.
OstiLox SPL
SPL · Structured Product Label
FDA Structured Product Label XML for OstiLox. Use the source link for the full official labeling record.
MELOXIDYL SPL
SPL · Structured Product Label
FDA Structured Product Label XML for MELOXIDYL. Use the source link for the full official labeling record.
MELOXIDYL SPL
SPL · Structured Product Label
FDA Structured Product Label XML for MELOXIDYL. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Metacam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Metacam. Use the source link for the full official labeling record.
MELOXIDYL SPL
SPL · Structured Product Label
FDA Structured Product Label XML for MELOXIDYL. Use the source link for the full official labeling record.
Metacam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Metacam. Use the source link for the full official labeling record.
Alloxate SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Alloxate. Use the source link for the full official labeling record.
OstiLox SPL
SPL · Structured Product Label
FDA Structured Product Label XML for OstiLox. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
Meloxivet SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxivet. Use the source link for the full official labeling record.
X SPL
SPL · Structured Product Label
FDA Structured Product Label XML for X. Use the source link for the full official labeling record.
Meloxicam SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Meloxicam. Use the source link for the full official labeling record.
FOI Summary oA 200-786 Approved April 20, 2026.pdf
FOI · FOI
FOI Summary oA 200-794 Approved August 14, 2025.pdf
FOI · FOI
FOI Summary oA 200-817 Approved July 21, 2025.pdf
FOI · FOI
FOI Summary oA 200-816 Approved July 11, 2025.pdf
FOI · FOI
FOI Summary oA 200-727 Approved July 29, 2022.pdf
FOI · FOI
ucm118027.pdf
FOI · FOI
ucm118026.pdf
FOI · FOI
ucm118008.pdf
FOI · FOI
ucm118006.pdf
FOI · FOI
UCM338146.pdf
FOI · FOI
UCM338160.pdf
FOI · FOI
UCM417720.pdf
FOI · FOI
UCM449223.pdf
FOI · FOI
UCM370746.pdf
FOI · FOI
UCM338139.pdf
FOI · FOI
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/18346 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/2479 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18646/Loxicom%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17325 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17646/Meloxisol%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17255 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17566/Meloxicam%20Oral%20Suspension · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17209 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17527/Meloxisol%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/12709 · document · FOI
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
-
Reference facts:
Source Roxee
| Refreshed Jun 22, 2026, 10:41 AM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Jun 22, 2026, 10:40 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed May 1, 2026, 10:01 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Jun 22, 2026, 10:41 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
Alloxate
Loxicom
MELOXIDYL
Meloxicam
Meloxivet
Metacam
OstiLox
Ostilox
X
Manufacturer mapping:
Multiple FDA labelers
Case-reported brands (openFDA):
MSK
Catalog species: Both
•
FDA-labeled species: Cat, Dog
Rx/OTC: RX
Form/route:
Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution, Transmucosal Oral Spray
• Intravenous, Oral, Subcutaneous
Applications: ANADA 200-786 • ANADA 200-794 • ANADA 200-817 • ANADA 200-816 • ANADA 200-727 • NADA 141-219 • NADA 141-213 • ANADA 200-485 • ANADA 200-491 • ANADA 200-540 • ANADA 200-497 • ANADA 200-550 • NADA 141-346
NDC:
Packages
0010-6013-01
0010-6014-01
0010-6014-02
0010-6015-01
0010-6015-02
0010-6015-03
•
Products
0010
11695
13744
13985
17033
46066
Explore
Related conditions:
Osteoarthritis (Degenerative Joint Disease)
Osteoarthritis (Degenerative Joint Disease)
Pain (acute, chronic)
Linked using:
Fda_Label (0.95),
Fda_Label (0.95),
Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: M19.90
Unspecified osteoarthritis, unspecified site
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Owner-facing counseling points
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1)
Dehydration (1)
Dehiscence (1)
Decreased cholesterol (1)
Decreased blood urea nitrogen (BUN) or creatinine (1)
Decreased appetite (1)
Death by euthanasia (1)
Death (1)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
ANADA: 200485
ANADA: 200491
ANADA: 200497
ANADA: 200540
ANADA: 200550
ANADA: 200727
ANADA: 200786
ANADA: 200794
ANADA: 200816
ANADA: 200817
NADA: 141213
NADA: 141219
NADA: 141346
NDC Package: 0010-6013-01
NDC Package: 0010-6014-01
NDC Package: 0010-6014-02
NDC Package: 0010-6015-01
NDC Package: 0010-6015-02
NDC Package: 0010-6015-03
NDC Package: 0010-6015-04
NDC Package: 11695-6936-1
NDC Package: 11695-6936-2
NDC Package: 11695-6966-1
NDC Package: 11695-6966-2
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0010-6013-01 | 0010 | - | |
| 0010-6014-01 | 0010 | - | |
| 0010-6014-02 | 0010 | - | |
| 0010-6015-01 | 0010 | - | |
| 0010-6015-02 | 0010 | - | |
| 0010-6015-03 | 0010 | - | |
| 0010-6015-04 | 0010 | - | |
| 11695-6936-1 | 11695 | - | |
| 11695-6936-2 | 11695 | - | |
| 11695-6966-1 | 11695 | - | |
| 11695-6966-2 | 11695 | - | |
| 11695-6966-3 | 11695 | - | |
| 11695-6966-4 | 11695 | - | |
| 11695-7008-1 | 11695 | - | |
| 11695-7008-2 | 11695 | - | |
| 11695-7050-1 | 11695 | - | |
| 11695-7067-1 | 11695 | - | |
| 11695-7067-2 | 11695 | - | |
| 13744-505-01 | 13744 | - | |
| 13744-505-10 | 13744 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
OstiLox SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Loxicom SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Metacam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Loxicom SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Ostilox SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
MELOXIDYL SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Loxicom SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
OstiLox SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
MELOXIDYL SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
MELOXIDYL SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Metacam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
MELOXIDYL SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Metacam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Alloxate SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
OstiLox SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxivet SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
X SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Meloxicam SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
A-200786-E-0003-OT-AA_PI.pdf
• Official label • Official
• April 30, 2026
FDA official labeling for application 200786
-
FOI Summary oA 200-786 Approved April 20, 2026.pdf
• FOI summary • Official
• April 30, 2026
FDA FOI summary for application 200786
-
FOI Summary oA 200-794 Approved August 14, 2025.pdf
• FOI summary • Official
• Aug. 28, 2025
FDA FOI summary for application 200794
-
FOI Summary oA 200-817 Approved July 21, 2025.pdf
• FOI summary • Official
• July 31, 2025
FDA FOI summary for application 200817
-
FOI Summary oA 200-816 Approved July 11, 2025.pdf
• FOI summary • Official
• July 31, 2025
FDA FOI summary for application 200816
-
A-200727-G-0031-FL-AA_PI.pdf
• Official label • Official
• Nov. 7, 2024
FDA official labeling for application 200727
-
FOI Summary oA 200-727 Approved July 29, 2022.pdf
• FOI summary • Official
• Nov. 7, 2024
FDA FOI summary for application 200727
-
N-141219-C-0098-NL-AA_PI.pdf
• Official label • Official
• March 1, 2024
FDA official labeling for application 141219
-
ucm118026.pdf
• FOI summary • Official
• March 1, 2024
FDA FOI summary for application 141219
-
ucm118027.pdf
• FOI summary • Official
• March 1, 2024
FDA FOI summary for application 141219
-
N-141213-G-0122-FL-AA_CIS.pdf
• Official label • Official
• Dec. 21, 2023
FDA official labeling for application 141213
-
N-141213-G-0122-FL-AA_CIS.pdf
• Official label • Official
• Dec. 21, 2023
FDA official labeling for application 141213
-
UCM422143.pdf
• Official label • Official
• Dec. 21, 2023
FDA official labeling for application 141213
-
UCM050394.pdf
• Official label • Official
• Dec. 21, 2023
FDA official labeling for application 141213
-
ucm118006.pdf
• FOI summary • Official
• Dec. 21, 2023
FDA FOI summary for application 141213
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 175
Clinical 1
Manufacturer 0
Marketing 0
Current Field Facts
- side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in 'Neurological'), Anorexia, Death by euthanasia, … (Clinical, 2026-04-11)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-04-12)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-04-11)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-02-12)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-22)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-22)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-21)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-20)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-13)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-12)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-12)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-11)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-11)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-10)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-09)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-08)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-07)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-06)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-05)
- indications: Dogs: For the control of pain and inflammation associated with osteoarthritis.Cats: For the control of postoperative pain and inflammation associated with orth… (Official, 2026-06-04)
Recent Revisions
- side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Loxicom®
RX
Meloxicam
Oral Suspension
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-786 | Approved | Apr 30, 2026 |
|
Meloxisol™
RX
Meloxicam
Oral Suspension
• Oral
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-794 | Approved | Aug 28, 2025 |
|
Meloxicam Oral Suspension
RX
Meloxicam
Oral Suspension
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-817 | Approved | Jul 31, 2025 |
|
Meloxisol™
RX
Meloxicam
Oral Suspension
• Oral
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-816 | Approved | Jul 31, 2025 |
|
Meloxicam
RX
Meloxicam
Injectable Solution
• Intravenous, Subcutaneous
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-727 | Approved | Nov 7, 2024 |
|
Metacam® 5 mg/mL Solution for Injection
RX
Meloxicam
Liquid (Solution)
• Subcutaneous, Intravenous
|
Boehringer Ingelheim Animal Health USA, Inc. | NADA 141-219 | Approved | Mar 1, 2024 |
|
Metacam® Oral Suspension
RX
Meloxicam
Liquid (Suspension)
• Oral
|
Boehringer Ingelheim Animal Health USA, Inc. | NADA 141-213 | Approved | Dec 21, 2023 |
|
Meloxicam Injection
RX
Meloxicam
Sterile Solution
• Subcutaneous, Intravenous
|
Accord Healthcare, Inc. | ANADA 200-485 | Approved | Jan 31, 2023 |
|
Loxicom®
RX
Meloxicam
Solution For Injection
• Intravenous, Subcutaneous
|
Norbrook Laboratories, Ltd. | ANADA 200-491 | Approved | Aug 2, 2021 |
|
Meloxicam Solution for Injection
RX
Meloxicam
Sterile Solution
• Intravenous, Subcutaneous
|
Dechra Veterinary Products LLC | ANADA 200-540 | Approved | Aug 18, 2020 |
|
Loxicom®
RX
Meloxicam
Oral Suspension
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-497 | Approved | Feb 27, 2019 |
|
Meloxidyl®
RX
Meloxicam
Oral Suspension
• Oral
|
Ceva Sante Animale | ANADA 200-550 | Approved | Dec 21, 2018 |
|
OroCAM® Transmucosal Oral Spray
RX
Meloxicam
Transmucosal Oral Spray
• Oral
|
Zoetis Inc. | NADA 141-346 | Approved | Nov 13, 2017 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
0.5 mg/mL
Dogs
Indication
Loxicom® oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on thefirst day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Limitations
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Limitations
FDA page: Open in Animal Drugs @ FDA
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Limitations
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
1.5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog • Cat
Composition / specifications
5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Meloxicam injection should be administered initially as a single dose, at0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.
Limitations
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose of Meloxicam injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated. To ensure accuracy of dosing, the use of a 1 mL graduated syringe is recommended.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: Dog • Cat
Composition / specifications
Each milliliter of solution contains 5.0 milligrams (mg) meloxicam.
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery.
Dosage
Administer 0.14 mg/lb (0.3 milligram per kilogram) body weight as a single, one-time subcutaneous injection.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer 0.09 mg per pound (0.2 milligram per kilogram) body weight by intravenous or subcutaneous injection on the first day of treatment. For treatment after day 1, administer meloxicam suspension orally at 0.045 mg/lb (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog
Composition / specifications
Each milliliter of suspension contains 0.5 or 1.5 milligrams (mg) meloxicam.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For oral use in dogs only.
Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.
FDA page: Open in Animal Drugs @ FDA
Species: Dog • Cat
Composition / specifications
5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.
Limitations
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated.
Limitations
Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
FDA page: Open in Animal Drugs @ FDA
Species: Dog • Cat
Composition / specifications
5 mg/mL meloxicam solution
Dogs
Indication
Indicated in dogs for the control of pain and inflammation
associated with osteoarthritis.
Dosage
Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously |IV| or subcutaneously (SQ), fallowed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight either mixed with food or placed directly in the mouth.
Limitations
Do not administer a second dose of meloxicam.
Do not follow the single, one-time dose of meloxicam with any other NSAID.
Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.
Cats
Indication
For the control ot postoperative pain and inflammation associated with orthopedic surgery, ovariohystarectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight.
Limitations
Do not administer a second dose of meloxicam.
Do not follow the single, one-time dose of meloxicam with any other NSAID.
Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.
FDA page: Open in Animal Drugs @ FDA
Species: Dog • Cat
Composition / specifications
5 mg/mL
<strong>Dogs</strong>
Indication
For the control of pain and inflammation associated with osteoarthritis
Dosage
Meloxicam Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
<strong>Cats</strong>
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery
Dosage
Administer a single, one-time subcutaneous dose of Meloxicam Solution for Injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Species: Dog
Composition / specifications
1.5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
On the first day of treatment, administer 0.09 mg/lb (0.2 mg/kg). For all treatments after day 1, administer once daily at a dose of 0.045 mg/lb (0.1 mg/ kg).
Limitations
For oral use in dogs only.
FDA page: Open in Animal Drugs @ FDA
Species: Dog
Composition / specifications
Each milliliter of suspension contains 1.5 milligrams (mg) meloxicam.
Label highlights
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs
Dosage
Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Species: Dog
Composition / specifications
Each milliliter of solution contains 5 milligrams (mg) meloxicam.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer 0.1 mg per kilogram of body weight once daily using the metered dose pump.
Limitations
For oral use in dogs only.
Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer meloxicam transmucosal oral spray to cats.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Usage
For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery. For the control of pain and inflammation associated with osteoarthritis in dogs.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Loss of appetite (1)
• Dog
Decreased appetite (1)
• Cat
Bloody diarrhoea (1)
• Dog
Blood in vomit (1)
• Cat
Appetite loss (1)
• Cat
Showing top 5 for Digestive.
Skin & allergy
Hair loss at application site (1)
• Cat
Biting - pruritus (1)
• Dog
Application site hair loss (1)
• Cat
Showing top 5 for Skin & allergy.
Neurologic
Unsteady walking (1)
• Dog
Showing top 5 for Neurologic.
Behavior
Behavioral disorder (1)
• Cat
Showing top 5 for Behavior.
Other
Dehydration (1)
• Cat
Dehiscence (1)
• Cat
Decreased cholesterol (1)
• Dog
Decreased blood urea nitrogen (BUN) or creatinine (1)
• Cat
Death by euthanasia (1)
• Cat
Show more (17)
Death (1)
• Cat
Cystitis (1)
• Cat
Crust (1)
• Cat
Cough (1)
• Dog
Constipation (1)
• Cat
Conjunctivitis (1)
• Dog
Closed eyelid (1)
• Cat
Blood in urine (1)
• Cat
Aspiration pneumonia (1)
• Dog
Application site skin scaling (1)
• Cat
Anaemia NOS (1)
• Cat
Adipsia (1)
• Cat
Abnormal ultrasound finding (1)
• Dog
Abnormal radiograph finding (1)
• Dog
Abnormal posture NOS (1)
• Dog
Abnormal cytology (1)
• Cat
Abdominal pain (1)
• Dog
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Domestic Shorthair, Male, 7 year, 8.618 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Injection site hair loss, Reddening of the skin, Weight loss, Skin lesion NOS, Wound… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-075379
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 7.00 Year
- Weight: 8.618 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
Reactions Reported:
Injection site hair loss
Reddening of the skin
Weight loss
Skin lesion NOS
Wound
Abnormal cytology
Discomfort NOS
Skin necrosis
Itching
Facial swelling (possible allergy)
Facial rash
Outcomes: Ongoing
Cat, Domestic Shorthair, Male, 13 year, 4.717 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Diarrhea • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-075145
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 13.00 Year
- Weight: 4.717 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Diarrhea
Outcomes: Ongoing
Dog, Spaniel - King Charles Cavalier, Male, 6 year, 7.711 kilogram • Drug: MSK, Suspension, Oral, Dose: 0.76 Milligram per dose, Frequency: 1 per day • Reactions: Unresponsive to stimuli, Limpness • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-075031
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 6.00 Year
- Weight: 7.711 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
- Dose: 0.76 Milligram per dose
- Frequency: 1 per day
Reactions Reported:
Unresponsive to stimuli
Limpness
Outcomes: Recovered/Normal
Dog, Chihuahua, Male, 4 year, 3.175 kilogram • Drug: MSK, Suspension, Oral, Dose: 1 Unknown per animal, Frequency: 1 per day • Reactions: Diarrhea, Loss of appetite, Lack of efficacy - NOS • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-074369
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 4.00 Year
- Weight: 3.175 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
- Dose: 1 Unknown per animal
- Frequency: 1 per day
Reactions Reported:
Diarrhea
Loss of appetite
Lack of efficacy - NOS
Outcomes: Recovered/Normal
Cat, Domestic Mediumhair, Male, 8.5 year, 5.27 kilogram • Drug: MSK, Unknown, Dose: 1.50 Milligram per animal • Reactions: Dysphoria, Sleep disturbance NOS, Hallucination, Third eyelid prolapse, Dilated pupils… • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-074168
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 8.50 Year
- Weight: 5.270 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Dose: 1.50 Milligram per animal
Reactions Reported:
Dysphoria
Sleep disturbance NOS
Hallucination
Third eyelid prolapse
Dilated pupils
Closed eyelid
Outcomes: Recovered/Normal
Dog, Chihuahua, Female, 8 year, 3.674 kilogram • Drug: MSK, Suspension, Oral, Dose: 0.10 Milligram per kilogram • Reactions: Cough, Bloody diarrhoea, Aspiration pneumonia, Vomiting, Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-074939
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 8.00 Year
- Weight: 3.674 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
- Dose: 0.10 Milligram per kilogram
Reactions Reported:
Cough
Bloody diarrhoea
Aspiration pneumonia
Vomiting
Death
Outcomes: Died
Dog, Terrier - Silky, Female, 13 year, 6.35 kilogram • Drug: MSK, Suspension, Oral, Dose: 0.63 Milligram per dose, Frequency: 24 per hour • Reactions: Loss of appetite, Haematochezia, Vomiting • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-074370
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 13.00 Year
- Weight: 6.350 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Suspension
- Dose: 0.63 Milligram per dose
- Frequency: 24 per hour
Reactions Reported:
Loss of appetite
Haematochezia
Vomiting
Outcomes: Outcome Unknown
Dog, Terrier - Jack Russell, Female, 13 year, 6.214 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Inappropriate elimination NOS, Proprioception deficit, Weight loss, Vomiting, Diarrhea… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-074255
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 13.00 Year
- Weight: 6.214 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Inappropriate elimination NOS
Proprioception deficit
Weight loss
Vomiting
Diarrhea
Proteinuria
Elevated globulins
Neutrophilia
Abnormal radiograph finding
Outcomes: Ongoing
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.